{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/meningitis-bacterial-meningitis-meningococcal-disease/goals-outcome-measures/nice-quality-standards/","result":{"pageContext":{"chapter":{"id":"141459fa-eb5f-51e0-a4f1-55aa8fcf568a","slug":"nice-quality-standards","fullItemName":"NICE quality standards","depth":2,"htmlHeader":"<!-- begin field 42ba5186-ae14-43bc-8bda-d19ad74f0096 --><h2>NICE quality standards</h2><!-- end field 42ba5186-ae14-43bc-8bda-d19ad74f0096 -->","summary":null,"htmlStringContent":"<!-- begin item dd17bb2c-0c9d-48a1-9458-76ff54abc7e9 --><!-- begin field fe8a772c-e1f4-420b-a375-08dcb0b772eb --><ul><li>Parents and carers of children and young people presenting with non-specific symptoms and signs are given 'safety netting' information that includes information on bacterial meningitis and meningococcal septicaemia.</li><li>Children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia have their temperature, respiratory rate, pulse, blood pressure, urine output, oxygen saturation, and neurological condition monitored at least hourly until stable.</li><li>Children and young people presenting with a petechial rash receive antibiotics in accordance with NICE guidance.</li><li>Children and young people with suspected bacterial meningitis or meningococcal septicaemia receive intravenous or intraosseous antibiotics within an hour of arrival at hospital.</li><li>Children and young people with suspected bacterial meningitis have a lumbar puncture.</li><li>Children and young people with suspected bacterial meningitis have their cerebrospinal fluid (CSF) microscopy result available within 4 hours of lumbar puncture.</li><li>Children and young people with suspected bacterial meningitis or meningococcal septicaemia have whole blood meningococcal polymerase chain reaction (PCR) testing.</li><li>Children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia, who have signs of shock or raised intracranial pressure, are assessed by a consultant paediatrician.</li><li>Children and young people with meningococcal septicaemia undergoing tracheal intubation and mechanical ventilation have the procedure undertaken by an anaesthetist experienced in paediatric airway management.</li><li>Children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia being transferred within or between hospitals are escorted by a healthcare professional trained in advanced paediatric life support.</li><li>Children and young people with suspected or confirmed bacterial meningitis or meningococcal septicaemia requiring transfer to a paediatric intensive care unit or high dependency unit in another hospital are transferred by a specialist paediatric retrieval team.</li><li>Children and young people who have had bacterial meningitis or meningococcal septicaemia, and/or their parents and carers, are given information before discharge about the disease, its potential long-term effects, and how to access further support.</li><li>Children and young people who have had bacterial meningitis or meningococcal septicaemia have an audiological assessment before discharge.</li><li>Children and young people who have had bacterial meningitis or meningococcal septicaemia have a follow-up appointment with a consultant paediatrician within 6 weeks of discharge.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">NICE, 2012</a>]</p><ul><li>People with suspected sepsis are assessed using a structured set of observations to stratify risk of severe illness or death.</li><li>People with suspected sepsis in acute hospital settings and at least 1 of the criteria indicating high risk of severe illness or death have an immediate review by a senior clinical decision-maker and antibiotics given within 1 hour if indicated.</li><li>People with suspected sepsis in acute hospital settings who need treatment to restore cardiovascular stability have an intravenous fluid bolus within 1 hour of risk being stratified.</li><li>People with suspected sepsis in acute hospital settings who receive intravenous antibiotics or fluid bolus are seen by a consultant if their condition fails to respond within 1 hour of initial treatment.</li><li>People with suspected sepsis who have been stratified as at low risk of severe illness or death are given information about symptoms to monitor and how to access medical care.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">NICE, 2017b</a>]</p><ul><li>Infants and children under 5 years with unexplained fever have their risk of serious illness assessed and recorded using the traffic light system.</li><li>Infants and children under 5 years who are seen in person by a healthcare professional have their temperature, heart rate, respiratory rate, and capillary refill time measured and recorded if fever is suspected.</li><li>Infants and children presenting with unexplained fever of 38Â°C or higher have a urine sample tested within 24 hours. See statement 1 of NICE's quality standard on urinary tract infection in infants, children and young people for the quality measures, what the quality statement means, source guidance and definitions.</li><li>Parents and carers who are advised that they can care for an infant or child under 5 years with unexplained fever at home are given safety net advice, including information on when to seek further help.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">NICE, 2014</a>]</p><!-- end field fe8a772c-e1f4-420b-a375-08dcb0b772eb --><!-- end item dd17bb2c-0c9d-48a1-9458-76ff54abc7e9 -->","topic":{"id":"5c52d7ca-c2cb-5551-ba9f-1fcdbdf1faad","topicId":"b3676823-9bef-422c-a1fe-011ca9f6883f","topicName":"Meningitis - bacterial meningitis and meningococcal disease","slug":"meningitis-bacterial-meningitis-meningococcal-disease","lastRevised":"Last revised in July 2020","chapters":[{"id":"12319bd7-3980-5b0c-8deb-b4351ef52f99","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"c72ab6e0-adbe-5cb4-9d67-4909820fb847","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"f9d67392-74e7-5adf-b712-fa42f7e69711","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"af144a12-5e1e-5d97-8d14-45db380ecef0","slug":"changes","fullItemName":"Changes"},{"id":"eb9e7802-cda3-5c04-b178-4ae4c2bb0003","slug":"update","fullItemName":"Update"}]},{"id":"9719c30a-3d48-51f7-8a76-d9a376cfc395","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"34af18fa-646e-5799-8eea-3070c9be3955","slug":"goals","fullItemName":"Goals"},{"id":"d1170912-4321-588d-88ca-217aea38c5c4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"777fba00-f0b7-56ca-aad8-482a8107aa53","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6162c8c1-72d4-5418-b083-e9261dc043af","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"8b16062f-23c7-57ef-9c04-d8696d43c468","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"141459fa-eb5f-51e0-a4f1-55aa8fcf568a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"45808ab8-48c2-500e-904e-b28b1dd9f2c1","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a71886c1-a30d-566c-84b9-d1fd02dbacd0","slug":"definition","fullItemName":"Definition"},{"id":"3bf2ba08-2574-58c3-9147-499dd2671f06","slug":"causes","fullItemName":"Causes"},{"id":"9d242c7b-d3c1-5081-8db2-1d366c43c71d","slug":"transmission","fullItemName":"Transmission"},{"id":"46f40806-a5d8-5742-ad5b-35abf21b89bb","slug":"prevalence","fullItemName":"Prevalence"},{"id":"20fadd0c-adea-5cb2-8cb7-cc9df62dd094","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"6f81c33d-8bac-5747-bd44-5b3244f57b58","slug":"complications","fullItemName":"Complications"},{"id":"6e9b6946-ed39-54a6-9e90-9989f22e636b","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"5bcb31df-47de-5f61-bdb9-90d4ff02c6c4","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"eeb07a78-3dda-516a-943d-8418d5224628","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"5644216d-a652-51b5-a696-c9e4aac4b609","slug":"assessing-the-rash","fullItemName":"Assessing the rash"},{"id":"2fb8dc81-2176-50e5-a2c5-1bb1541cddfc","slug":"assessing-vital-signs","fullItemName":"Assessing vital signs"},{"id":"0f916e0f-ed47-5988-843a-19af47c3726d","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"75dbccb7-b3c5-51dc-8069-f497798fd646","fullItemName":"Management","slug":"management","subChapters":[{"id":"1b657d07-eb89-5d3b-9404-ef623a716920","slug":"non-blanching-rash-or-meningococcal-septicaemia","fullItemName":"Scenario: Non-blanching rash or meningococcal septicaemia"},{"id":"414935f6-7030-5ea4-a397-cac8958da2c7","slug":"without-non-blanching-rash","fullItemName":"Scenario: Without non-blanching rash"},{"id":"d532e29d-6fc3-54b3-b286-b1e80ce7840c","slug":"managing-close-contacts","fullItemName":"Scenario: Managing close contacts"},{"id":"81e1e9d4-a4c9-5c10-80d9-07cc83d6dba2","slug":"follow-up-after-hospital-discharge","fullItemName":"Scenario: Follow up after hospital discharge"}]},{"id":"c620569e-fa7a-5c2c-a708-ec6432bf5c51","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9f59f8a5-e555-56ba-861a-a492cfe5a298","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"9c42a3ff-6a45-5e6c-a247-51a81848f67a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"50077a62-1fb9-5968-a1e6-71ac64bcf7e1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7e85d7bc-8751-5e8f-8e77-8b91b0cf1141","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"7fb74eaa-420c-5cdd-a04e-92cbd9be478c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"b8d54b7e-8c9b-5d53-8a0a-6a7296727eb4","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"71898679-d838-5f6d-8422-64c378e43045","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"9719c30a-3d48-51f7-8a76-d9a376cfc395","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}